This week's dividend activity included increased payouts from Advanced Materials (AMAT) and Dick's Sporting Goods (DKS) as ...

Merck's stock dropped 1.37% in the latest session, underperforming the S&P 500’s 0.49% gain. Despite this, Merck has surged 9 ...

Merck & Co. has received an average "Moderate Buy" rating from 23 analysts, with a $116.39 target price. Several analysts ...

Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

Vaccinex, Inc. (OTC: VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative ...

Preparations for submission of a Biologics License Application (BLA) for Cylembio® (imsapepimut and etimupepimut, adjuvanted) to FDA by year end 2025 remain on track. The trial completed enrollment in ...

You can also opt for USA + Canada plans. Ubigi is a fully independent mobile virtual network operator (MVNO), operating on its own core network infrastructure, which means users will have higher ...

I want to note that Keytruda's exclusivity ends in 2028 only in the USA, while Europe will not see its biosimilars until 2031 and Japan until 2032/2033. So, from Merck's pipeline of experimental ...

The Levis logo is as recognisable a global brand as the likes of Coca-Cola, Apple, Nike but what do the symbols on the back of each pair of denims mean ? Levi Strauss & Co. features at the top of ...

Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...